NDA 12265, held by Schering. Trichlormethiazide, Reserpine; Trichlormethiazide.
As of Nov 13, 2026, NDA 12265 (Naqua, Naquival), held by Schering, was first approved by FDA on Mar 9, 1960, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 9, 1960 | Original applicationNew molecular entity · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Naqua2MG · tablet;oral | Trichlormethiazide | Discontinued |
| Naqua4MG · tablet;oral | Trichlormethiazide | Discontinued |
| Naquival0.1MG;4MG · tablet;oral | Reserpine; Trichlormethiazide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
